Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-10-15 Purchase |
2024-10-17 1:58 pm |
Aditxt Inc. | ADTX | HRT FINANCIAL LP 10% Owner |
15,636 | $1.5 | $23,454 | 0 (Direct) |
View |
| 2024-10-16 Sale |
2024-10-17 1:58 pm |
Aditxt Inc. | ADTX | HRT FINANCIAL LP 10% Owner |
25,534 | $1.17 | $29,875 | 0 (Direct) |
View |
| 2023-09-07 Sale |
2023-09-07 5:41 pm |
Aditxt Inc. | ADTX | BNP PARIBAS SECURITIES CORP Reduced under 10% owner |
20,800 | $33.23 | $691,140 | 22,342 (Direct) |
View |
| 2021-06-01 Purchase |
2021-06-02 5:38 pm |
Aditx Therapeutics Inc. | ADTX | Runge Jeffrey W. Director |
10,000 | $2.9344 | $29,344 | 12,500 (Direct) |
View |
| 2021-06-01 Purchase |
2021-06-02 4:37 pm |
Aditx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER |
490 | $2.93 | $1,436 | 1,016,098 (Indirect) |
View |
| 2021-06-01 Purchase |
2021-06-02 12:20 pm |
Aditx Therapeutics Inc. | ADTX | Albanna Amro A. CHIEF EXECUTIVE OFFICER |
3,400 | $2.9335 | $9,974 | 751,620 (Direct) |
View |
| 2021-06-01 Purchase |
2021-06-02 12:19 pm |
Aditx Therapeutics Inc. | ADTX | Albanna Rowena CHIEF OPERATING OFFICER |
3,400 | $2.9335 | $9,974 | 751,620 (Indirect) |
View |
| 2021-05-25 Purchase |
2021-05-28 6:49 pm |
Aditx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER |
602 | $2.4876 | $1,498 | 2,031,031 (Indirect Direct) |
View |
| 2021-05-26 Purchase |
2021-05-27 1:16 pm |
Aditx Therapeutics Inc. | ADTX | Farley Thomas J PRINCIPAL ACCOUNTING OFFICER |
2,500 | $2.6799 | $6,700 | 2,500 (Direct) |
View |
| 2021-05-25 Purchase |
2021-05-25 8:03 pm |
Aditx Therapeutics Inc. | ADTX | Pankovcin Corinne CHIEF FINANCIAL OFFICER |
4,220 | $2.56 | $10,803 | 114,220 (Direct) |
View |
| 2020-07-02 Purchase |
2021-02-12 4:05 pm |
Aditx Therapeutics Inc. | ADTX | Kiaie Namvar Director |
1,111 | $0 | $0 | 3,333 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2024-10-17 1:31 pm |
N/A N/A |
Aditxt Inc. | ADTX | HRT FINANCIAL LP 10% Owner |
0 | $0 | 25,434 (Direct) |
View |
| 2023-11-08 Option Award |
2023-11-13 4:30 pm |
N/A 2033-11-08 |
Aditxt Inc. | ADTX | Runge Jeffrey W. Director |
470 | $0 | 470 (Direct) |
View |
| 2023-11-08 Option Award |
2023-11-13 4:30 pm |
N/A 2033-11-08 |
Aditxt Inc. | ADTX | Nelson Charles Athle Director |
470 | $0 | 470 (Direct) |
View |
| 2023-11-08 Option Award |
2023-11-13 4:30 pm |
N/A 2033-11-08 |
Aditxt Inc. | ADTX | Albanna Rowena Chief Operating Officer |
4,702 | $0 | 4,702 (Direct) |
View |
| 2023-11-08 Option Award |
2023-11-13 4:30 pm |
N/A 2033-11-08 |
Aditxt Inc. | ADTX | Albanna Amro A. Chief Executive Officer |
9,404 | $0 | 9,404 (Direct) |
View |
| 2023-11-08 Option Award |
2023-11-13 4:30 pm |
N/A 2033-11-08 |
Aditxt Inc. | ADTX | Pankovcin Corinne CCO |
4,702 | $0 | 4,702 (Direct) |
View |
| 2023-11-08 Option Award |
2023-11-13 4:30 pm |
N/A 2033-11-08 |
Aditxt Inc. | ADTX | Farley Thomas J Chief Financial Officer |
4,702 | $0 | 4,702 (Direct) |
View |
| 2023-11-08 Option Award |
2023-11-13 4:30 pm |
N/A 2033-11-08 |
Aditxt Inc. | ADTX | Brady Brian Michael Director |
470 | $0 | 470 (Direct) |
View |
| 2023-11-08 Option Award |
2023-11-13 4:30 pm |
N/A 2033-11-08 |
Aditxt Inc. | ADTX | Shabahang Shahrokh Chief Innovation Officer |
7,053 | $0 | 7,053 (Direct) |
View |
Ownership |
2023-09-05 5:08 pm |
N/A N/A |
Aditxt Inc. | ADTX | BNP PARIBAS SECURITIES CORP 10% Owner |
0 | $0 | 32,942 (Direct) |
View |
Ownership |
2022-02-03 6:43 pm |
N/A N/A |
Aditxt Inc. | ADTX | Shatzkes Matthew Chief Legal Officer and GC |
0 | $0 | 480,000 (Direct) |
View |
| 2021-07-22 Option Award |
2021-11-12 9:51 pm |
N/A N/A |
Aditxt Inc. | ADTX | Albanna Rowena Chief Operating Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-07-22 Option Award |
2021-11-12 9:50 pm |
N/A N/A |
Aditxt Inc. | ADTX | Shabahang Shahrokh Chief Innovation Officer |
105,000 | $0 | 105,000 (Direct) |
View |
| 2021-07-22 Option Award |
2021-11-12 9:49 pm |
N/A N/A |
Aditxt Inc. | ADTX | Farley Thomas J Chief Financial Officer |
155,000 | $0 | 155,000 (Direct) |
View |
| 2021-07-14 Option Award |
2021-10-01 9:45 pm |
N/A N/A |
Aditxt Inc. | ADTX | Chung Lauren Director |
14,000 | $0 | 28,000 (Direct) |
View |
| 2021-09-29 Option Award |
2021-10-01 7:05 pm |
N/A N/A |
Aditxt Inc. | ADTX | Kiaie Namvar Director |
11,500 | $0 | 11,500 (Direct) |
View |
| 2021-09-29 Option Award |
2021-10-01 7:04 pm |
N/A N/A |
Aditxt Inc. | ADTX | Brady Brian Michael Director |
11,500 | $0 | 11,500 (Direct) |
View |
| 2021-09-29 Option Award |
2021-10-01 7:02 pm |
N/A N/A |
Aditxt Inc. | ADTX | ANTHONY LAURA E Director |
11,500 | $0 | 11,500 (Direct) |
View |
| 2021-09-29 Option Award |
2021-10-01 7:00 pm |
N/A N/A |
Aditxt Inc. | ADTX | Runge Jeffrey W. Director |
11,500 | $0 | 11,500 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-08 4:06 pm |
N/A N/A |
Aditx Therapeutics Inc. | ADTX | Albanna Amro A. CHIEF EXECUTIVE OFFICER |
75,000 | $0 | 826,620 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-08 4:05 pm |
N/A N/A |
Aditx Therapeutics Inc. | ADTX | Albanna Rowena CHIEF OPERATING OFFICER |
75,000 | $0 | 826,620 (Indirect) |
View |
| 2021-06-04 Option Award |
2021-06-08 4:05 pm |
N/A N/A |
Aditx Therapeutics Inc. | ADTX | Pankovcin Corinne CHIEF FINANCIAL OFFICER |
55,000 | $0 | 169,220 (Direct) |
View |
Ownership |
2021-03-30 11:59 am |
N/A 2030-11-02 |
Aditx Therapeutics Inc. | ADTX | Farley Thomas J PRINCIPAL ACCOUNTING OFFICER |
0 | $0 | 60,000 (Direct) |
View |
| 2021-03-17 Exercise |
2021-03-22 4:16 pm |
2018-03-17 2021-03-17 |
Aditx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER |
18,750 | $0 | 1,015,006 (Indirect) |
View |
| 2021-03-17 Exercise |
2021-03-22 4:16 pm |
N/A N/A |
Aditx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER |
18,750 | $4 | 1,015,006 (Indirect) |
View |
| 2021-02-24 Option Award |
2021-03-01 06:14 am |
N/A N/A |
Aditx Therapeutics Inc. | ADTX | Albanna Rowena CHIEF OPERATING OFFICER |
225,000 | $0 | 772,220 (Indirect) |
View |
| 2021-02-24 Option Award |
2021-03-01 06:13 am |
N/A N/A |
Aditx Therapeutics Inc. | ADTX | Pankovcin Corinne CHIEF FINANCIAL OFFICER |
110,000 | $0 | 110,000 (Direct) |
View |
| 2021-02-24 Option Award |
2021-03-01 06:11 am |
N/A N/A |
Aditx Therapeutics Inc. | ADTX | Albanna Amro A. CHIEF EXECUTIVE OFFICER |
225,000 | $0 | 772,220 (Direct) |
View |
| 2020-07-22 Ownership |
2021-02-12 4:05 pm |
2020-07-02 2025-07-02 |
Aditx Therapeutics Inc. | ADTX | Kiaie Namvar Director |
1,111 | $11.25 | 3,333 (Direct) |
View |